long QT syndrome

Researchers saw clinically actionable heart disease mutations in fewer than 5 percent of sudden infant death syndrome cases interrogated by molecular autopsy.

Researchers find that energy drinks could be dangerous for patients with familial long QT syndrome, according to Live Science.

This Week in PNAS

In PNAS this week: sequencing approaches to characterize cisplatin-mediated DNA damage, somatic mosaicism in long-QT syndrome case, and more.

The study, focused on two genes associated with cardiac disorders, found that patient phenotypes did not correlate with the presence or absence of a pathogenic variant.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.

NEW YORK (GenomeWeb) – A recently launched lawsuit in Canada challenging the practice of patenting genomic DNA is also asking the Federal Court to determine that advanced diagnostics utilizing next-generation sequencing platforms do not infringe patents on older testing methods involving the ampl

This article has been updated with the name of the US laboratory that sent Ontario's Ministry of Health a cease and desist letter.
NEW YORK (GenomeWeb) – The Children's Hospital of Eastern Ontario is challenging the legality of US gene patents in Canada.

NEW YORK (GenomeWeb News) – InformedDNA today said that it is providing genetic counseling to certain members of health plan Cigna.

ChanTest will develop non-clinical assays, databases, and computational models for assessing the risk of serious cardiac events associated with drug-induced QT prolongation.

The Canada Foundation for Innovation will support various university research and lab enhancement projects.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.